BioPharma Dive August 15, 2022
The Challenge
Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.
As a result, pharmaceutical representatives’ access to physicians has been declining even prior to the COVID-19 pandemic.
Although 80% of healthcare providers (HCPs) identified as “rep-accessible” in 2008 (that is, willing to meet with over 70% of the sales reps who try to approach them), that number had decreased to 44% in 2017. The percentage of healthcare providers willing to see pharmaceutical company reps in-person had declined from 67% in 2018 to 54% in 2019.
Throughout the pandemic, physician access has become even more of a challenge. A survey of physicians found that only 20% of...
Today's Sponsors
Today's Sponsor